Dr Michael Falster

Dr Michael Falster

Senior Lecturer
  • PhD, UNSW Sydney, 2017
  • Masters of Biostatistics, University of Sydney, 2011
  • Bachelor of Psychology (Hons), UNSW Sydney, 2005
Medicine & Health
School of Population Health

My research uses population-level data and advanced analytics to measure quality, use and outcomes of care across the Australian health system.

I am a Senior Research Fellow and Heart Foundation Future Leader Fellow in the Medicines Intelligence Research Program at the School of Population Health, UNSW. I am also Deputy Director of Research, School of Population Health. I lead research on NHMRC and Heart Foundation funded grants, using population-level linked hospital, pharmaceutical, Medicare and mortality data. My work has shaped national reporting of leading health performance indicators, informed new national models of primary care, and supported development of enduring national linked data assets that bridge hospital and community care.

I partner with academics, clinicians and policymakers to identify evidence-practice gaps across the continuum of hospital and community care. I have high-level technical expertise in ‘big data’ analytics, (pharmaco-)epidemiology and biostatistics, I have specialised capabilities in translating complex real-world evidence to policy and practice. My aim is to improve access to quality care for all Australians.

Examples of my research interests include:

  • improving uptake of best-practice cardiovascular medicines within high-risk populations
  • identifying disparities in care between public and privately funded patients
  • comparing outcomes between people receiving different health interventions in real-world settings
  • evaluating models of chronic disease care to prevent unnecessary hospital admissions.
Phone
02 9385 0698
Location
Room 219, Samuels Building (F25)
  • Journal articles | 2024
    Daniels B; Luckett T; Liauw W; Falster MO; Gisev N; Blyth FM; Pearson SA, 2024, 'Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study', Journal of Pain and Symptom Management, 68, pp. 282 - 291.e11, http://dx.doi.org/10.1016/j.jpainsymman.2024.06.006
    Journal articles | 2024
    Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson S-A; Falster MO, 2024, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.', Eur Heart J Qual Care Clin Outcomes, http://dx.doi.org/10.1093/ehjqcco/qcae068
    Journal articles | 2024
    Lin J; De Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO, 2024, 'Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia', Journal of Hypertension, 42, pp. 1248 - 1255, http://dx.doi.org/10.1097/HJH.0000000000003721
    Journal articles | 2024
    Milder TY; Lin J; Pearson SA; Greenfield JR; Day RO; Stocker SL; Neuen BL; Falster MO; de Oliveira Costa J, 2024, 'Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018–2022', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16231
    Journal articles | 2024
    Neuen BL; Heerspink HJL; Vart P; Claggett BL; Fletcher RA; Arnott C; de Oliveira Costa J; Falster MO; Pearson SA; Mahaffey KW; Neal B; Agarwal R; Bakris G; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria', Circulation, 149, pp. 450 - 462, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067584
    Journal articles | 2024
    Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, http://dx.doi.org/10.1016/j.jacc.2024.08.006
    Journal articles | 2024
    Stehlik P; Dowsett C; Camacho X; Falster MO; Lim R; Nasreen S; Pratt NL; Pearson SA; Henry D, 2024, 'Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol', BMJ Open, 14, pp. e079071, http://dx.doi.org/10.1136/bmjopen-2023-079071
    Journal articles | 2024
    Tran DT; Falster MO; Pearse J; Mazevska D; McElduff P; Pearson S; van Gool KC; Hall J; Jorm L, 2024, 'The Australian Health Care Homes trial: quality of care and patient outcomes. A propensity score-matched cohort study', Medical Journal of Australia, 220, pp. 372 - 378, http://dx.doi.org/10.5694/mja2.52266
    Journal articles | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5887
    Journal articles | 2024
    af Geijerstam P; Falster MO; Chalmers J; McLachlan AJ; Rodgers A; Schutte AE, 2024, 'Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting', Hypertension Research, 47, pp. 2104 - 2114, http://dx.doi.org/10.1038/s41440-024-01743-2
    Journal articles | 2024
    de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes, Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597
    Journal articles | 2023
    Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO; de Oliveira Costa J, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264
    Journal articles | 2023
    Falster MO; Garland SK; Jorm LR; Beiles CB; Freeman AJ; Sedrakyan A; Sotade OT; Varcoe RL, 2023, 'Comparison of Outcomes for Major Contemporary Endograft Devices Used for Endovascular Repair of Intact Abdominal Aortic Aneurysms', JOURNAL OF VASCULAR SURGERY, 77, pp. 1293 - 1293, http://dx.doi.org/10.1016/j.jvs.2023.01.009
    Journal articles | 2023
    Falster MO; Garland SK; Jorm LR; Beiles CB; Freeman AJ; Sedrakyan A; Sotade OT; Varcoe RL, 2023, 'Editor's Choice – Comparison of outcomes for major contemporary endograft devices used for endovascular repair of intact abdominal aortic aneurysms', European Journal of Vascular and Endovascular Surgery, 65, pp. 272 - 280, http://dx.doi.org/10.1016/j.ejvs.2022.11.005
    Journal articles | 2023
    Garland SK; Falster MO; Beiles CB; Freeman AJ; Jorm LR; Sedrakyan A; Sotade O; Varcoe RL, 2023, 'Long-Term Outcomes Following Elective Repair of Intact Abdominal Aortic Aneurysms: A Comparison Between Open Surgical and Endovascular Repair Using Linked Administrative and Clinical Registry Data', Annals of Surgery, 277, pp. E955 - E962, http://dx.doi.org/10.1097/SLA.0000000000005259
    Journal articles | 2023
    Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8
    Journal articles | 2023
    Mao J; Behrendt CA; Falster MO; Varcoe RL; Zheng X; Peters F; Beiles B; Schermerhorn ML; Jorm L; Beck AW; Sedrakyan A, 2023, 'Long-term Mortality and Reintervention after Endovascular and Open Abdominal Aortic Aneurysm Repairs in Australia, Germany, and the United States', Annals of Surgery, 278, pp. E626 - E633, http://dx.doi.org/10.1097/SLA.0000000000005768
    Journal articles | 2023
    Robijn AL; Filion KB; Woodward M; Hsu B; Chow CK; Pearson SA; Jorm L; Falster MO; Havard A, 2023, 'Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events', Heart, 109, pp. 1016 - 1024, http://dx.doi.org/10.1136/heartjnl-2022-322170
    Journal articles | 2023
    Shawon MSR; Falster MO; Hsu B; Yu J; Ooi SY; Jorm L, 2023, 'Trends and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in New South Wales from 2008 to 2019', American Journal of Cardiology, 187, pp. 110 - 118, http://dx.doi.org/10.1016/j.amjcard.2022.10.047
    Journal articles | 2023
    Sotade OT; Falster MO; Pearson SA; Jorm LR; Sedrakyan A, 2023, 'Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years', Journal of Thoracic and Cardiovascular Surgery, 166, pp. 728 - 737.e13, http://dx.doi.org/10.1016/j.jtcvs.2022.01.016
    Journal articles | 2023
    de Oliveira Costa J; Pearson SA; Brieger D; Lujic S; Shawon MSR; Jorm LR; van Gool K; Falster MO, 2023, 'In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals', International Journal for Equity in Health, 22, pp. 226, http://dx.doi.org/10.1186/s12939-023-02030-1
    Journal articles | 2022
    Falster MO; Schaffer AL; Wilson A; Nasis A; Jorm LR; Hay M; Leeb K; Pearson SA; Brieger D, 2022, 'Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia', Internal Medicine Journal, 52, pp. 249 - 258, http://dx.doi.org/10.1111/imj.15036
    Journal articles | 2022
    Lujic S; Randall DA; Simpson JM; Falster MO; Jorm LR, 2022, 'Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', Scientific Reports, 12, pp. 14139, http://dx.doi.org/10.1038/s41598-022-18346-x
    Journal articles | 2022
    Quiroz JC; Brieger D; Jorm LR; Sy RW; Falster MO; Gallego B, 2022, 'An Observational Study of Clinical and Health System Factors Associated With Catheter Ablation and Early Ablation Treatment for Atrial Fibrillation in Australia', Heart Lung and Circulation, 31, pp. 1269 - 1276, http://dx.doi.org/10.1016/j.hlc.2022.04.049
    Journal articles | 2022
    Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735
    Journal articles | 2022
    Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA, 2022, 'Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients', Heart Lung and Circulation, 31, pp. 1144 - 1152, http://dx.doi.org/10.1016/j.hlc.2022.04.048
    Journal articles | 2022
    Sotade OT; Pearson SA; Jorm LR; Kushwaha VV; Sedrakyan A; Falster MO, 2022, 'Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018', Heart Lung and Circulation, 31, pp. e17 - e19, http://dx.doi.org/10.1016/j.hlc.2021.09.010
    Journal articles | 2021
    De Oliveira Costa J; Pearson SA; Elshaug AG; Van Gool K; Jorm LR; Falster MO, 2021, 'Rates of Low-Value Service in Australian Public Hospitals and the Association with Patient Insurance Status', JAMA Network Open, 4, pp. e2138543, http://dx.doi.org/10.1001/jamanetworkopen.2021.38543
    Journal articles | 2021
    Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B, 2021, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', British Journal of Clinical Pharmacology, 87, pp. 1264 - 1274, http://dx.doi.org/10.1111/bcp.14504
    Journal articles | 2021
    Lujic S; Randall D; Simpson J; Falster M; Jorm L, 2021, '1467Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.402
    Journal articles | 2021
    Quiroz JC; Brieger D; Jorm L; Sy RW; Falster MO; Gallego B, 2021, 'An observational study of clinical and health system factors associated with catheter ablation and early ablation treatment for atrial fibrillation in Australia', , pp. 2021.09.03.21263104, http://dx.doi.org/10.1101/2021.09.03.21263104
    Journal articles | 2021
    Shawon MSR; Odutola M; Falster MO; Jorm LR, 2021, 'Patient and hospital factors associated with 30-day readmissions after coronary artery bypass graft (CABG) surgery: a systematic review and meta-analysis', Journal of Cardiothoracic Surgery, 16, pp. 172, http://dx.doi.org/10.1186/s13019-021-01556-1
    Journal articles | 2020
    Coleman L; Brett J; Daniels B; Pearson S; Falster M, 2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, 31, http://dx.doi.org/10.17061/phrp30452015
    Journal articles | 2020
    Darshni A; Farshid A; MacIsaac A; Hsu B; Pearson S; Falster M; Hyun K; D'Silva M; Brieger D, 2020, '730 Exploration of Single Antiplatelet Drug use in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Cardiac Stenting', Heart, Lung and Circulation, 29, pp. S364 - S365, http://dx.doi.org/10.1016/j.hlc.2020.09.737
    Journal articles | 2020
    Falster MO; Buckley NA; Brieger D; Pearson SA, 2020, 'Antihypertensive polytherapy in Australia: Prevalence of inappropriate combinations, 2013-2018', Journal of Hypertension, 38, pp. 1586 - 1592, http://dx.doi.org/10.1097/HJH.0000000000002408
    Journal articles | 2020
    Hsu B; Falster MO; Schaffer AL; Pearson S; Jorm L; Brieger DB, 2020, 'Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation', Medical Journal of Australia, 213, pp. 124 - 125, http://dx.doi.org/10.5694/mja2.50507
    Journal articles | 2020
    Sotade OT; Falster M; Girardi LN; Pearson SA; Jorm LR, 2020, 'Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients', BMJ Surgery, Interventions, and Health Technologies, 2, pp. e000036, http://dx.doi.org/10.1136/bmjsit-2020-000036
    Journal articles | 2019
    Falster MO; Leyland AH; Jorm LR, 2019, 'Do hospitals influence geographic variation in admission for preventable hospitalisation? A data linkage study in New South Wales, Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-027639
    Journal articles | 2019
    Page AT; Falster MO; Litchfield M; Pearson SA; Etherton-Beer C, 2019, 'Polypharmacy among older Australians, 2006–2017: a population-based study', Medical Journal of Australia, 211, pp. 71 - 75, http://dx.doi.org/10.5694/mja2.50244
    Journal articles | 2019
    Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287
    Journal articles | 2018
    Falster MO; Jorm LR; Leyland AH, 2018, 'Using Weighted Hospital Service Area Networks to Explore Variation in Preventable Hospitalization', Health Services Research, 53, pp. 3148 - 3169, http://dx.doi.org/10.1111/1475-6773.12777
    Journal articles | 2018
    Johnson TL; Kaldor J; Falster MO; Sutherland K; Humphries J; Jorm LR; Levesque JF, 2018, 'Predictive risk modelling under different data access scenarios: Who is identified as high risk and for how long?', BMJ Open, 8, pp. e018909, http://dx.doi.org/10.1136/bmjopen-2017-018909
    Journal articles | 2018
    Tran B; Falster M; Jorm L, 2018, 'Claims-based measures of continuity of care have non-linear associations with health: data linkage study', International Journal of Population Data Science, 3, pp. 463, http://dx.doi.org/10.23889/ijpds.v3i1.463
    Journal articles | 2018
    Tran B; Straka P; Falster MO; Douglas KA; Britz T; Jorm LR, 2018, 'Overcoming the data drought: Exploring general practice in Australia by network analysis of big data', Medical Journal of Australia, 209, pp. 68 - 73, http://dx.doi.org/10.5694/mja17.01236
    Journal articles | 2018
    Van Leeuwen MT; Falster MO; Vajdic CM; Crowe PJ; Lujic S; Klaes E; Jorm L; Sedrakyan A, 2018, 'Reoperation after breast-conserving surgery for cancer in Australia: Statewide cohort study of linked hospital data', BMJ Open, 8, pp. e020858, http://dx.doi.org/10.1136/bmjopen-2017-020858
    Journal articles | 2017
    Falster M; Jorm L; Leyland A, 2017, 'Exploring health events around preventable hospitalisations through visualisation of linked health data.', International Journal of Population Data Science, 1, http://dx.doi.org/10.23889/ijpds.v1i1.103
    Journal articles | 2017
    Falster M; Jorm L; Leyland A, 2017, 'Using weighted hospital service area networks to explore variation in preventable hospitalisation.', International Journal of Population Data Science, 1, http://dx.doi.org/10.23889/ijpds.v1i1.104
    Journal articles | 2017
    Möller H; Falster K; Ivers R; Falster MO; Clapham K; Jorm L, 2017, 'Closing the Aboriginal child injury gap: targets for injury prevention', Australian and New Zealand Journal of Public Health, 41, pp. 8 - 14, http://dx.doi.org/10.1111/1753-6405.12591
    Journal articles | 2016
    Falster K; Banks E; Lujic S; Falster M; Lynch J; Zwi K; Eades S; Leyland AH; Jorm L, 2016, 'Inequalities in pediatric avoidable hospitalizations between Aboriginal and non-Aboriginal children in Australia: A population data linkage study', BMC Pediatrics, 16, http://dx.doi.org/10.1186/s12887-016-0706-7
    Journal articles | 2016
    Falster MO; Jorm LR; Leyland AH, 2016, 'Visualising linked health data to explore health events around preventable hospitalisations in NSW Australia', BMJ Open, 6, pp. e012031, http://dx.doi.org/10.1136/bmjopen-2016-012031
    Journal articles | 2016
    Möller H; Falster K; Ivers R; Falster M; Randall D; Clapham K; Jorm L, 2016, 'Inequalities in hospitalized unintentional injury between aboriginal and non-aboriginal children in New South Wales, Australia', American Journal of Public Health, 106, pp. 899 - 905, http://dx.doi.org/10.2105/AJPH.2015.303022
    Journal articles | 2016
    Tran B; Falster MO; Girosi F; Jorm L, 2016, 'Relationship between use of general practice and healthcare costs at the end of life: A data linkage study in New South Wales, Australia', BMJ Open, 6, pp. e009410, http://dx.doi.org/10.1136/bmjopen-2015-009410
    Journal articles | 2015
    Falster MO; Jorm LR; Douglas KA; Blyth FM; Elliott RF; Leyland AH, 2015, 'Sociodemographic and health characteristics, rather than primary care supply, are major drivers of geographic variation in preventable hospitalizations in Australia', Medical Care, 53, pp. 436 - 445, http://dx.doi.org/10.1097/MLR.0000000000000342
    Journal articles | 2015
    Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic C, 2015, 'Diagnosis of hepatitis c virus infection after entry to opioid substitution therapy', Drug and Alcohol Dependence, 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.337
    Journal articles | 2015
    Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic CM, 2015, 'Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study', Drug and Alcohol Dependence, 148, pp. 213 - 216, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.027
    Journal articles | 2015
    Moeller H; Ivers R; Falster K; Falster M; Clapham K; Jorm L; Randall D, 2015, 'The Contribution Of Geography And Risk Factors To Inequalities In Unintentional Injury Between Aboriginal And Non-Aboriginal Australian Children', ISEE Conference Abstracts, 2015, pp. 349 - 349, http://dx.doi.org/10.1289/isee.2015.2015-349
    Journal articles | 2015
    Tran B; Falster MO; Douglas K; Blyth F; Jorm LR, 2015, 'Smoking and potentially preventable hospitalisation: The benefit of smoking cessation in older ages', Drug and Alcohol Dependence, 150, pp. 85 - 91, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.028
    Journal articles | 2015
    Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'Corrigendum to "The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study" [Drug Alcohol Depend. 152C (2015) 264-271] DOI: 10.1016/j.drugalcdep.2015.03.026', Drug and Alcohol Dependence, 154, pp. 304, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.024
    Journal articles | 2015
    Vajdic CM; Pour SM; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study', Drug and Alcohol Dependence, 152, pp. 264 - 271, http://dx.doi.org/10.1016/j.drugalcdep.2015.03.026
    Journal articles | 2015
    Warren JR; Falster MO; Tran B; Jorm L, 2015, 'Association of continuity of primary care and statin adherence', PLoS ONE, 10, pp. e0140008, http://dx.doi.org/10.1371/journal.pone.0140008
    Journal articles | 2014
    Harrold TC; Randall DA; Falster MO; Lujic S; Jorm LR, 2014, 'The contribution of geography to disparities in preventable hospitalisations between indigenous and non-indigenous Australians', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0097892
    Journal articles | 2014
    Tran B; Falster MO; Douglas K; Blyth F; Jorm LR, 2014, 'Health behaviours and potentially preventable hospitalisation: A prospective study of older Australian adults', PLoS ONE, 9, pp. e93111, http://dx.doi.org/10.1371/journal.pone.0093111
    Journal articles | 2014
    Vajdic CM; Stavrou EP; Ward RL; Falster MO; Pearson SA, 2014, 'Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study', Australian and New Zealand Journal of Public Health, 38, pp. 30 - 34, http://dx.doi.org/10.1111/1753-6405.12168
    Journal articles | 2014
    Van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM, 2014, 'Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006', International Journal of Cancer, 135, pp. 2146 - 2156, http://dx.doi.org/10.1002/ijc.28849
    Journal articles | 2013
    Falster MO; Randall DA; Lujic S; Ivers R; Leyland AH; Jorm LR, 2013, 'Disentangling the impacts of geography and Aboriginality on serious road transport injuries in New South Wales', Accident Analysis and Prevention, 54, pp. 32 - 38, http://dx.doi.org/10.1016/j.aap.2013.01.015
    Journal articles | 2013
    Jorm LR; Randall DA; Falster MO; Leyland AH, 2013, 'OP08 Using Linked Administrative Data and Multilevel Modelling to Identify Targets for Interventions to Tackle Health Disparities', Journal of Epidemiology and Community Health, 67, pp. A7.1 - A7, http://dx.doi.org/10.1136/jech-2013-203126.8
    Journal articles | 2013
    Van Leeuwen MT; Turner J; Falster M; Meagher N; Joske D; Grulich AE; Giles GG; Vajdic CM, 2013, 'Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure', International Journal of Cancer, 133, pp. 944 - 951, http://dx.doi.org/10.1002/ijc.28081
    Journal articles | 2013
    Warren JR; Falster MO; Fox D; Jorm L, 2013, 'Factors influencing adherence in long-term use of statins', Pharmacoepidemiology and Drug Safety, 22, pp. 1298 - 1307, http://dx.doi.org/10.1002/pds.3526
    Journal articles | 2012
    Becker N; Falster M; Vajdic CM; De Sanjose S; Martinez-Maza O; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Constantin A; Holly EA; Spinelli JJ; Vecchia CL; Zheng T; Chiu BC-H; Montella M; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE, 2012, 'Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis', International Journal of Cancer, 131, pp. 2342 - 2348, http://dx.doi.org/10.1002/ijc.27438
    Journal articles | 2012
    Falster M; Roberts C; Ford JB; Kinnear A; Nicholl M, 2012, 'Development of a maternity hospital classification for perinatal research', NSW Public Health Bulletin, 1, pp. 12 - 16
    Journal articles | 2012
    Jorm LR; Leyland AH; Blyth FM; Elliott RF; Douglas KMA; Redman S, 2012, 'Assessing Preventable Hospitalisation InDicators (APHID): Protocol for a data-linkage study using cohort study and administrative data', BMJ Open, 2, http://dx.doi.org/10.1136/bmjopen-2012-002344
    Journal articles | 2012
    Morris JM; Algert CS; Falster MO; Ford JB; Kinnear A; Nicholl MC; Roberts CL, 2012, 'Trends in planned early birth: A population-based study', American Journal of Obstetrics and Gynecology, 207, pp. 186.e1 - 186.e8, http://dx.doi.org/10.1016/j.ajog.2012.06.082
    Journal articles | 2010
    Grulich AE; Vajdic CM; Falster M; Kane E; Ekstrom SK; Bracci P; De Sanjose S; Becker NG; Turner J; Martinez-Maza O; Melbye M; Engels E; Vineis P; Seniori CA; Holly E; Spinelli J; La Vecchia C; Zheng T; Chiu B; Dal Maso L; Cocco P, 2010, 'Birth order and risk of non-Hodgkins Lymphoma - true association or bias?', American Journal of Epidemiology, 172, pp. 621 - 630, http://dx.doi.org/10.1093/aje/kwq167
    Journal articles | 2009
    Poynten IM; Millwood I; Falster M; Law MG; Andresen DN; Van Damme L; Kaldor JM, 2009, 'The safety of candidate vaginal microbicides since nonoxynol-9: A systematic review of published studies', AIDS, 23, pp. 1245 - 1254
    Journal articles | 2009
    Vajdic CM; Falster M; De Sanjose S; Martinez-Maza O; Becker N; Bracci P; Melbye M; Smedby K; Engels E; Turner J; Vineis P; Costantini A; Holly E; Kane E; Spinelli J; La Vecchia C; Zheng T; Chiu B; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan J; Breen E; Birmann B; Cozen W; Grulich AE, 2009, 'Atopic disease and risk of non-Hodgkin lymphoma: An interlymph pooled analysis', Cancer research, 69, pp. 6482 - 6489
    Journal articles | 2008
    Smedby K; Vajdic CM; Falster M; Engels E; Martinez-Maza O; Turner J; Hjalgrim H; Vineis P; Costantini A; Bracci P; Holly E; Willett E; Spinelli J; La Vecchia C; Zheng T; Becker NG; De Sanjose S; Chiu B; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan J; Breen E; Birmann B; Grulich AE; Cozen W, 2008, 'Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium', Blood, 111, pp. 4029 - 4038, http://dx.doi.org/10.1182/blood-2007-10-119974
    Journal articles | 2007
    Grulich AE; Van Leeuwen MT; Falster M; Vajdic CM, 2007, 'Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis', Lancet, 370, pp. 59 - 67, http://dx.doi.org/10.1016/S0140-6736(07)61050-2
  • Preprints | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520
    Conference Abstracts | 2023
    Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M; de Oliveira Costa J, 2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', in Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues, presented at Australian Diabetes Congress 2023
    Conference Abstracts | 2022
    Daniels B; Luckett T; Falster MO; Liauw W; Gisev N; Pearson S-A, 2022, 'Understanding opioid use prior to and immediately following cancer diagnosis using group-based trajectory models (GBTM)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 525 - 526, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Falster MO; Garland SK; Jorm L; Beiles CB; Freeman AJ; Sedrakyan A; Sotade O; Varcoe RL, 2022, 'Comparison of outcomes for major contemporary endograft devices used for endovascular repair of intact abdominal aortic aneurysms', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 466 - 467, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2022
    James P; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf
    Conference Abstracts | 2022
    Lujic S; Randall DA; Simpson JM; Falster MO; Jorm LR, 2022, 'Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', in Scientific Reports, Vol. 12, http://dx.doi.org/10.1038/s41598-022-18346-x
    Reports | 2022
    Pearse J; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf
    Reports | 2022
    Pearse J; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 2: Main report, https://www.health.gov.au/resources/publications/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022
    Conference Presentations | 2022
    Shawon MSR; Falster M; Hsu B; Yu J; Ooi S-Y; Jorm L, 2022, 'Temporal trends in rates and risk-adjusted outcomes for coronary revascularization in New South Wales (2003-2017)', presented at UNSW Annual Cardiovascular Symposium 2022, UNSW Sydney, 05 April 2022 - 05 April 2022
    Conference Abstracts | 2021
    Costa JDO; Pearson S-A; Elshaug A; van Gool K; Jorm L; Falster M, 2021, 'Rates of low value care in NSW public hospitals: variation between public and private inpatients', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, Vol. 50, http://dx.doi.org/10.1093/ije/dyab168.195
    Reports | 2021
    Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S; Dunbar J; McDermott R; Smyth T; Henryks J; Bower M; Rosen R; Sutch S; McDonald K; Lethborg A; Dove C, 2021, Evaluation of the Health Care Homes program - Interim evaluation report 2020 Volume 1: Summary report, https://www1.health.gov.au/internet/main/publishing.nsf/Content/Evaluation-of-the-Health-Care-Homes-Program
    Conference Abstracts | 2021
    Shawon MSR; Falster M; Lujic S; Hanly M; Garland S; Jorm L, 2021, 'Predictors and Sources of Variation in 30-day Unplanned Readmission Following Isolated Coronary Artery Bypass Graft (CABG) Surgery in Australia', in Heart Lung and Circulation, Elsevier, presented at 69th CSANZ Annual Scientific Meeting 43rd Annual Scientific Meeting of the International Society for Heart Research ANZET 21, http://dx.doi.org/10.1016/j.hlc.2021.06.362
    Conference Papers | 2021
    Sotade O; Falster M; Pearson S-A; Jorm L; Sedrakyan A, 2021, 'Comparison of 10-and 15-year outcomes of bioprosthetic and mechanical aortic valve replacement in patients aged under 65 years: Australian study using linked data for 4,704 patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2021
    Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)
    Reports | 2021
    Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5)
    Conference Abstracts | 2020
    Falster MO; Buckley NA; Brieger D; Pearson S-A, 2020, 'Antihypertensive polytherapy in Australia: Prevalence of inappropriate combinations, 2013-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 198 - 199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Falster MO; Charrier R; Pearson S; Buckley N; Daniels B, 2020, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Virtual, Vol. 29, pp. 199 - 199, presented at 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, 16 September 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2020
    Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S; Dunbar J; McDermott R; Smyth T; Henryks J; Bower M; Rosen R; Sutch S; McDonald K; Lethborg A; Dove C, 2020, Evaluation of the Health Care Homes program - Interim evaluation report 2019, Volume 1: Summary report
    Reports | 2020
    Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes PHN Benchmark Report: January 2020 - June 2020 (Round 4)
    Reports | 2020
    Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes PHN Benchmark Report: June 2019 - December 2019 (Round 3)
    Reports | 2020
    Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes Practice Benchmark Report: January 2020 - June 2020 (Round 4)
    Reports | 2020
    Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes Practice Benchmark Report: June 2019 - December 2019 (Round 3)
    Reports | 2019
    Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S, 2019, Evaluation of the Health Care Homes program - Evaluation plan
    Reports | 2019
    Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Practice Benchmark Report: February 2018 - December 2018 (Round 1)
    Reports | 2019
    Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Practice Benchmark Report: February 2018 - June 2019 (Round 2)
    Reports | 2019
    Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - December 2018 (Round 1)
    Reports | 2019
    Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - June 2019 (Round 2)
    Conference Abstracts | 2018
    Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia
    Conference Abstracts | 2018
    Falster M; Schaffer A; Jorm L; Wilson A; Brieger D; Nasis A; Emerson L; Pearson S, 2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640
    Conference Abstracts | 2018
    Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand
    Reports | 2018
    Schaffer A; Falster M; Pearson S; Jorm L; Wilson A; Nasis A; Brieger D, 2018, Delivering better cardiac outcomes: Primary, specialist and hospital care
    Conference Papers | 2012
    Morris J; Roberts C; Falster M, 2012, 'Outcomes of planned birth before the due date', in AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, MOSBY-ELSEVIER, TX, Dallas, pp. S279 - S280, presented at 32nd Annual Scientific Meeting/Pregnancy Meeting of Society-for-Maternal-Fetal-Medicine, TX, Dallas, 06 February 2012 - 11 February 2012, http://dx.doi.org/10.1016/j.ajog.2011.10.640
    Conference Papers | 2012
    Venkateswaran R; Adelstein B; Falster M; Ward R, 2012, 'IS TUMOUR HER-2 STATUS A PROGNOSTIC FACTOR IN GASTRIC AND OESOPHAGEAL CANCERS? A SYSTEMATIC REVIEW', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Falster M; Olivier J; Chong S; Grzebieta R; Watson W, 2009, 'Trends in severe pedestrian injuries among older people in NSW', in 2009 Australasian Road Safety Research, Policing and Education Conference, Roads and Traffic Authority of New South Wales, Australia, Sydney, Australia, presented at 2009 Australasian Road Safety Research, Policing and Education Conference, Sydney, Australia, 10 November 2009 - 13 November 2009, http://www.rsconference.com/roadsafety/detail/988

  • Heart Foundation 45 and Up Study Award 2022. Novel antidiabetic medicines in NSW adults with Type II Diabetes: disparities in the uptake, guideline adherence and treatment persistence. (Chief Investigator B)
  • Heart Foundation Future Leader Fellowship 2021. Using big data to inform post-hospital treatment decisions with cardiovascular medicines: variation, adherence and outcomes of care. (Chief investigator A)
  • NHMRC Ideas Grant 2021. Hospital trajectories for 15 million Australians. (Associate Investigator)
  • NHMRC Ideas Grant 2020. Disentangling the interrelationship between multimordibity, multimedicine use, and cardiovascular health. (Acting Chief Investigator A)
  • NHMRC Ideas Grant 2019. Same patient, same care: is our funding of hospitals promoting inequities in care and outcomes?. (Chief Investigator A)
  • NHMRC Project Grant 2018. Post-surgery care fragmentation: impacts and implications. (Chief Investigator D)
  • NHMRC Early Career Fellowship 2017. Using big data to reduce inappropriate medication use. (Chief Investigator A)

  • Internal Medicine Journal. Top Cited Article 2021-2022. 2023
  • Medical Journal of Australia. Top 10% most read research paper 2018-2019. 2020
  • NSW Cardiovascular Research Network. Professional Development Award. 2020
  • UNSW Faculty of Medicine. Dean’s Award for Outstanding Contribution to Research by a Higher Degree Research Student, 2017
  • Health Services Research Association of Australia and New Zealand. Best PhD Student Prize. 2016
  • National Health and Medical Research Council. "10 of the Best" Research Projects, Indigenous Health outcomes Patient Evaluation (IHOPE) Study. 2015 (Team member)
  • UNSW Graduate Research School. Travel Scholarship, C9-Go8 Forum - Big Data: Graduate Perspectives from China and Australia, Nanjing University. 2015
  • UNSW Faculty of Medicine. Top ranked oral presentation, Postgraduate Research Symposium. 2015

I have a body of research exploring variation in quality care across the health system, particularly using linked administrative health data. Current programs of research include: variation in best-practice cardiovascular medicine (e.g. between patients, sectors of the health system); disparities in hospital care between public and privately funded hospital inpatients (e.g. receipt of innovative procedures, length of stay and low value care); and long-term patient outcomes following a variety of surgical procedures.

I have a track record of research which engages with health policy. My prior research in the National Data Linkage Demonstration Project was the first research in Australia to use whole-of-population linked hospital, pharmaceutical dispensing and Medicare claims data - finding significant evidence-practice gaps in the use of critical cardiovascular medicines following hospital admission for a myocardial infarction. My PhD research exploring sources of variation in 'potentially preventable hospitalisations' reshaped the way we conceptualise this national health performance indicator. I have drafted interpretive guidelines for it's national reporting, and have been on multiple advisory groups and Committees including the Australian Institute of Health and Welfare ("Australia's Health 2020), the Australian Commission on Safety and Quality in Health Care ("Australian Atlas of Healthcare Variation") and the National Health Performance Authority.

My Research Supervision

I currently supervise:

  • One Masters of Health Data Science student (primary supervisor)

I have previously supervised to completion:

  • Two PhD students (joint-supervisor)
  • Two Masters of Health Data Science students (co-supervisor)
  • One Masters of Applied Statistics (Ecole Polytechnique, France) student (primary supervisor)
  • Six Masters of Biostatistics students (biostatistical supervisor)
  • Four Medical Honours / Independent Learning Project students (primary and co-supervisor)

My Teaching

I currently teach in the following subjects: 

  • HDAT9100 - Context of Health Data Science (Chapter instructor, 2018 - present)

I have previously taught in the following subjects, short courses and workshops:

  • HDAT9400 - Management and Curation of Health Data (Guest lecturer, 2018-2020)
  • Advanced Analysis of Linked Data (Tutor, 2017)
  • Managing Big Data in Health Research (Lecturer, 2015-2016)
  • Health in Context: A Course in Multilevel Modelling in Public Health and Health Services Research (Guest lecturer and tutor, 2013)